title: Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
abstract: We designed a study to assess the effects of standardization procedures on reducing interobserver variability for outcome measures given in the current Food Drug Administration and European League Against Rheumatism guidelines and others selected from the rheumatology literature. Over 2 days, 6 rheumatologists independently examined 7 patients with ankylosing spondylitis (AS) in predetermined order before and after standardizing their examination techniques. An important and beneficial effect of the standardization procedure was observed on the majority of outcome variables. Such reductions in observer variability have the potential to diminish sample size requirements for AS antirheumatic drug studies.
authors.affiliation: Division of Rheumatology, University of Western Ontario, London, Canada.
authors.forename: N
authors.initials: N
authors.lastname: Bellamy
authors.forename: W W
authors.initials: WW
authors.lastname: Buchanan
authors.forename: J M
authors.initials: JM
authors.lastname: Esdaile
authors.forename: A G
authors.initials: AG
authors.lastname: Fam
authors.forename: W F
authors.initials: WF
authors.lastname: Kean
authors.forename: J M
authors.initials: JM
authors.lastname: Thompson
authors.forename: G A
authors.initials: GA
authors.lastname: Wells
authors.forename: J
authors.initials: J
authors.lastname: Campbell
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D015588:Observer Variation; D012015:Reference Standards; D012107:Research Design; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D013223:Statistics as Topic
chemical_list: D000893:Anti-Inflammatory Agents